Old Web
English
Sign In
Acemap
>
Paper
>
A Human Ribonuclease Variant and ERK-Pathway Inhibitors Exhibit Highly Synergistic Toxicity for Cancer Cells
A Human Ribonuclease Variant and ERK-Pathway Inhibitors Exhibit Highly Synergistic Toxicity for Cancer Cells
2018
Trish T. Hoang
Ismet Caglar Tanrikulu
Quinn A. Vatland
Trieu M. Hoang
Ronald T. Raines
Keywords:
Toxicity
Cancer cell
Cancer research
Chemistry
MAPK/ERK pathway
Ribonuclease
synergistic toxicity
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]